Feature Channels:

AIDS and HIV

Add to Favorites Subscribe Share
SchoolMedicine_logo_1c_rgb_h.png
  • Embargo expired:
    22-Jan-2020 1:00 PM EST

Researchers Reverse HIV Latency, Important Scientific Step Toward Cure

University of North Carolina School of Medicine

Overcoming HIV latency – activating HIV in CD4+ T cells that lay dormant – is a needed step toward a cure. Scientists at UNC-Chapel Hill, Emory University, and Qura Therapeutics – a partnership between UNC and ViiV Healthcare – showed it’s possible to drive HIV out of latency in two animal models.

Channels: AIDS and HIV, Blood, Healthcare, Immunology, Infectious Diseases, Pharmaceuticals, National Institute of Allergy and Infectious Diseases (NIAID), Nature (journal), All Journal News,

Released:
21-Jan-2020 11:10 AM EST
Newswise: Blood Stem Cell Research

Blood Stem Cell Research

University of Delaware

A nanoparticle carrier system that could eliminate the need for bone marrow transplants, which are both expensive and difficult for patients to undergo. The University of Delaware's Emily Day, an assistant professor of biomedical engineering, is developing a platform that could treat stem cells directly without the need to remove them from the body.

Channels: AIDS and HIV, Biotech, Blood, Healthcare, Stem Cells,

Released:
15-Jan-2020 2:05 PM EST
Research Results
Newswise: Suo_photo.jpg

FSU study aids fight against HIV, hepatitis B

Florida State University

A discovery by Florida State University College of Medicine researchers is expected to open the door for new and more potent treatment options for many of the more than 36 million people worldwide infected with the HIV virus and for others chronically ill with hepatitis B.

Channels: AIDS and HIV, Immunology, Infectious Diseases, Pharmaceuticals, All Journal News,

Released:
8-Jan-2020 4:15 PM EST
Announcement
UTSW_logo.png

Intervention for patients hospitalized with HIV improved reengagement and outcomes of care

UT Southwestern Medical Center

Providing multidisciplinary team consults for HIV patients while they are hospitalized to help address social and medical barriers reduces future infection rates and boosts participation in follow-up care, results from a study on how to reengage patients show.

Channels: AIDS and HIV, Healthcare, Race and Ethnicity, National Institute of Allergy and Infectious Diseases (NIAID), National Institute on Drug Abuse (NIDA), All Journal News,

Released:
7-Jan-2020 5:45 PM EST
Research Results
Research Results
WoltersKluwer_CMYK-ol.jpg

Managing HIV/HCV Drug Interactions – JANAC Presents an Update for Nurses

Wolters Kluwer Health: Lippincott Williams and Wilkins

New direct-acting antiviral (DAA) medications are highly effective in curing patients with hepatitis C virus (HCV). But these drugs carry a risk of interactions with antiretroviral therapy (ART) used to control HIV. An update on management of drug interactions in patients coinfected with HIV/HCV is presented in The Journal of the Association of Nurses in AIDS Care (JANAC). The official journal of the Association of Nurses in AIDS Care, JANAC is published in the Lippincott portfolio by Wolters Kluwer.

Channels: Pharmaceuticals, AIDS and HIV, Healthcare, Infectious Diseases, Nursing, Immunology, All Journal News,

Released:
26-Dec-2019 2:35 PM EST
Research Results
LurieLogo.png

New study shows pregnant women with HIV often not given recommended treatment

Ann and Robert H. Lurie Children's Hospital of Chicago

Pregnant women living with HIV don’t always receive antiretroviral medications recommended for use in pregnancy, according to a recent study published in Jama Network Open this week. Ann & Robert H. Lurie Children's Hospital of Chicago’s researchers collaborated in the multi-site Surveillance Monitoring for ART Toxicities (SMARTT) study of the Pediatric HIV/AIDS Cohort Study (PHACS) network.

Channels: AIDS and HIV, Clinical Trials, Healthcare, OBGYN, Pharmaceuticals, Women's Health, JAMA, All Journal News,

Released:
20-Dec-2019 4:45 PM EST
Research Results
IDSA HIVMA Joint Logo.png

FY 2020 Spending Bill Funds Critical Initiatives While Neglecting Urgent Priorities

Infectious Diseases Society of America (IDSA) and the HIV Medicine Association (HIVMA)

The spending bill passed today is a welcome step forward. Allocations in the bill will strengthen public health and research efforts during the year ahead and will provide critical support for important goals. At the same time, the legislation in its final form also brings inadequate responses to current and urgent challenges with the potential for long-term and costly consequences.

Channels: AIDS and HIV, Budgets and Funding, Government/Law, Infectious Diseases, Public Health,

Released:
19-Dec-2019 2:45 PM EST
Research Results

Law and Public Policy

Newswise: A Decade in Review: 7 Healthcare Breakthroughs

A Decade in Review: 7 Healthcare Breakthroughs

University of California, Los Angeles (UCLA), Health Sciences

UCLA Health experts weigh in on the most significant healthcare advances of the last ten years and what exciting developments we can look forward to in the decade ahead.

Channels: AIDS and HIV, All Journal News, Alzheimer's and Dementia, Cancer, Cardiovascular Health, Neuro, Nutrition, Sleep, Food Science,

Released:
18-Dec-2019 3:50 PM EST
Policy
UTHEALTH_logo.jpg

Novel drug purified and developed from Amazon rainforest tree sap being studied for treatment of chronic diarrhea

University of Texas Health Science Center at Houston

A drug purified and developed from the sap of a tree in the Amazon rainforest is now being studied for the treatment of chronic idiopathic diarrhea in non-HIV patients at The University of Texas Health Science Center at Houston (UTHealth) as part of a two-year pilot study.

Channels: AIDS and HIV, All Journal News, Clinical Trials, Pharmaceuticals,

Released:
16-Dec-2019 11:05 AM EST
Feature Tip Sheet


9.58827